Tanzania Depression Therapeutics Market Analysis

Tanzania Depression Therapeutics Market Analysis


$ 3999

Tanzania's depression therapeutics market is expected to grow from $4 Mn in 2022 to $6 Mn in 2030 with a CAGR of 6.1% for the forecasted year 2022-2030. The growing demand for effective depression treatments and the rising government initiatives to promote awareness about depression in Tanzania are responsible for the expansion of the market. The Tanzania depression therapeutics market is segmented by drug type, therapies, indication, and end users. Tanga Pharmaceuticals, Afya Bora Pharma, and AbbVie are the major players in the Tanzania depression therapeutics market.

ID: IN10TZPH034 CATEGORY: Pharmaceuticals GEOGRAPHY: Tanzania AUTHOR: Dr. Parul Choudhary

Buy Now

Tanzania Depression Therapeutics Market Executive Analysis

Tanzania's depression therapeutics market size is at around $4 Mn in 2022 and is projected to reach $6 Mn in 2030, exhibiting a CAGR of 6.1% during the forecast period. Tanzania is moving toward universal healthcare; in 2020-21, the government allotted $387.9 Mn for the health sector, $155.5 Mn of which will be spent on development projects to assist the government in implementing its health-improving initiatives.  In 2022-23, the sector will be allotted $0.47 Bn. International donors supplement healthcare funding by contributing up to 40% of the health budget.  The US government contributes significantly to Tanzanian government assistance initiatives through USAID and the CDC. Health insurance coverage remains poor, with only 32% of Tanzanians having health insurance as of 2019.  Only 1% of those people have private health insurance.

In Tanzania, the point prevalence of depression was linked with lower self-reported physical health status and a large treatment gap. Depression had a crude and corrected prevalence rate of 21.2. Antidepressants are used to treat mood disorders such as anxiety and depression, as well as pain and sleeping problems. The most commonly prescribed form of antidepressant is selective serotonin reuptake inhibitor (SSRI), which includes Sertraline, Fluoxetine, and Citalopram. Serotonin and norepinephrine reuptake inhibitors (SNRIs) are comparable to SSRIs. Venlafaxine and duloxetine are two examples. Bupropion functions differently than SSRIs and SNRIs. It also helps individuals quit smoking and treats seasonal affective disorder. Tricyclics, tetracyclic, and monoamine oxidase inhibitors (MAOIs) are examples of older antidepressant drugs. Because they cause more side effects than other medications, they are given less frequently. They are, however, more effective for some individuals.

Tanzania Depression Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers

Depression is a prevalent mental health illness in Tanzania, with prevalence rates increasing in recent years. As a result, there is a larger demand for effective depression treatments, which is anticipated to drive market development. In Tanzania, there is increasing consciousness and acceptance of mental health problems, which has aided to reduce the stigma associated with depression. This may lead to a rise in the number of people seeking therapy for depression and an increase in the demand for depression therapeutics. Tanzania's government has made measures to address mental health matters, such as developing a mental health policy and opening mental health clinics. These initiatives have the potential to expand access to depression treatments while also driving the Tanzania depression therapeutics market development.

Market Restraints

Tanzania is a low-income country with poor healthcare access, especially in rural areas. This may make it difficult for people suffering from depression to acquire effective treatment, restraining market development. Depression medicines can be expensive, making them unaffordable for many Tanzanians. This could stifle market growth. Tanzania has restricted public capital for mental health services, which may limit the availability of depression treatments and slow the Tanzania depression therapeutics market growth.

Competitive Landscape

Key Players

  • Salama Pharmaceuticals (TZA)
  • Shelys Pharmaceutical (TZA)
  • Zenufa Laboratories (TZA)
  • Tanga Pharmaceuticals (TZA)
  • Afya Bora Pharma (TZA)
  • AbbVie
  • AstraZeneca
  • Bristol-Myers Squibb
  • Cipla
  • Eli Lily
  • GlaxoSmithKline
  • Johnson & Johnson

Healthcare Policies and Regulatory Landscape

The National Health Insurance Fund (NHIF) is a Social Health Insurance Institution created under the National Health Insurance Act, Cap 395, with the primary goal of ensuring that people have access to healthcare services. It is a government agency that reports to the Ministry of Health, Community Development, Gender, the Elderly, and Children (MHCDGEC). Despite the compulsory enrollment arrangement for public servants, the Fund's coverage has expanded to include Councilors, private companies, educational institutions, private individuals, children under the age of 18, farmers in cooperatives, and organized registered groups such as Machinga and Bodaboda groups. The Bunge Health Insurance Scheme, which serves members of the Zanzibar House of Representatives, is also administered by the Fund. The Fund covers the costs of medicines given in generic names, as well as medical consumables, according to the National Essential Medicines List (NEMLIT) and an extra medicine list suggested (to NHIF) by experts and stakeholders. In Tanzania, there are no particular reimbursement policies in effect for depression therapeutics. The NHIF usually reimburses healthcare providers for services rendered to patients, but the amount of reimbursement varies based on the service and provider.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Depression Therapeutics Segmentation

By Drug Type (Revenue, USD Billion):

  • Antidepressants
  • Anxiolytics
  • Anticonvulsants
  • Noradrenergic Agents
  • Atypical Antipsychotics

By Therapies (Revenue, USD Billion):

  • Electroconvulsive Therapy (ECT)
  • Cognitive Behaviour Therapy (CBT)
  • Psychotherapy
  • Deep Brain Stimulation
  • Transcranial Magnetic Stimulation (TMS)
  • Cranial electrotherapy stimulation (CES)

By Indication (Revenue, USD Billion):

  • Major Depressive Disorder (MDD)
  • Bipolar Disorder
  • Dysthymic Disorder
  • Postpartum Depression
  • Seasonal Affective Disorder (SAD)
  • Premenstrual Dysphoric Disorder (PMDD)
  • Others

By End Users (Revenue, USD Billion):

  • NGOs
  • Asylums
  • Hospitals
  • Mental Healthcare Centers

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.

Tanga Pharmaceuticals, Afya Bora Pharma, and AbbVie are the major players in the Tanzania depression therapeutics market.

The Tanzania depression therapeutics market is expected to grow from $4 Mn in 2022 to $6 Mn in 2030 with a CAGR of 6.1% for the forecasted year 2022-2030.

The Tanzania depression therapeutics market is segmented by drug type, therapies, indication, and by end users.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 23 October 2023
Updated by: Keta Vora

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up